Lifeward Ltd. (NASDAQ:LFWD) Short Interest Update

Lifeward Ltd. (NASDAQ:LFWD) was the target of a large decline in short interest in February. As of February 27th, there was short interest totaling 228,488 shares, a decline of 90.3% from the February 12th total of 2,351,929 shares. Based on an average trading volume of 41,420 shares, the short-interest ratio is currently 5.5 days. Approximately 15.2% of the company’s stock are sold short. Approximately 15.2% of the company’s stock are sold short. Based on an average trading volume of 41,420 shares, the short-interest ratio is currently 5.5 days.

Institutional Investors Weigh In On Lifeward

Institutional investors and hedge funds have recently modified their holdings of the business. Citadel Advisors LLC boosted its holdings in Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after purchasing an additional 198,406 shares in the last quarter. Virtu Financial LLC raised its holdings in Lifeward by 158.0% during the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after buying an additional 37,037 shares in the last quarter. Jane Street Group LLC lifted its position in shares of Lifeward by 77.3% in the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after buying an additional 29,927 shares during the last quarter. Finally, HRT Financial LP lifted its position in shares of Lifeward by 149.7% in the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after buying an additional 29,423 shares during the last quarter. Institutional investors and hedge funds own 26.76% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on LFWD. HC Wainwright cut their price objective on Lifeward from $156.00 to $54.00 and set a “buy” rating for the company in a report on Tuesday, November 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Lifeward in a research report on Thursday, January 22nd. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $54.00.

Lifeward Trading Up 5.2%

NASDAQ LFWD traded up $0.33 during trading on Wednesday, reaching $6.68. The company’s stock had a trading volume of 9,358 shares, compared to its average volume of 29,574. The stock has a market capitalization of $10.18 million, a PE ratio of -0.19 and a beta of 0.12. Lifeward has a 1-year low of $4.14 and a 1-year high of $35.40. The business has a 50-day moving average price of $6.98 and a 200-day moving average price of $7.43.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.